» Authors » Richard Wesseloo

Richard Wesseloo

Explore the profile of Richard Wesseloo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 226
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Molenaar N, Poels E, Robakis T, Wesseloo R, Bergink V
Focus (Am Psychiatr Publ) . 2024 May; 22(1):120-125. PMID: 38694160
Objectives: Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by...
2.
Schrijver L, Kamperman A, Bijma H, van Kamp I, Wesseloo R, Hoogendijk W, et al.
Acta Psychiatr Scand . 2024 Jan; 149(4):323-331. PMID: 38238613
Introduction: Lithium use during pregnancy reduces the risk of mood episodes in the perinatal period for women with bipolar disorder. Some previous studies found deleterious effects of intrauterine lithium exposure...
3.
Poels E, Sterrenburg K, Wierdsma A, Wesseloo R, Beerthuizen A, van Dijke L, et al.
J Psychopharmacol . 2020 Jul; 35(2):178-183. PMID: 32684118
Background: Lithium is an effective treatment in pregnancy and postpartum for the prevention of relapse in bipolar disorder, but there is a lack of knowledge about the potential adverse impact...
4.
Molenaar N, Poels E, Robakis T, Wesseloo R, Bergink V
Bipolar Disord . 2020 Jun; 23(1):49-54. PMID: 32526071
Objectives: Recommendations on lithium dosing around delivery vary, with several guidelines suggesting that lithium should be discontinued prior to delivery. We aimed to evaluate the validity of these recommendations by...
5.
Munk-Olsen T, Liu X, Viktorin A, Brown H, Di Florio A, DOnofrio B, et al.
Lancet Psychiatry . 2018 Jun; 5(8):644-652. PMID: 29929874
Background: Concerns about teratogenicity and maternal and offspring complications restrict the use of lithium during pregnancy for the treatment of mood disorders. We aimed to investigate the association between in-utero...
6.
Wesseloo R, Kamperman A, Bergink V, Pop V
J Affect Disord . 2017 Aug; 225:399-403. PMID: 28850854
Background: During the postpartum period, women are at risk for the new onset of both auto-immune thyroid disorders and depression. The presence of thyroid peroxidase antibodies (TPO-ab) during early gestation...
7.
Kamperman A, Veldman-Hoek M, Wesseloo R, Robertson Blackmore E, Bergink V
Bipolar Disord . 2017 Jul; 19(6):450-457. PMID: 28699248
Objectives: Postpartum psychosis (PP) is known for its clear onset but its phenotype has never been clearly described in a cohort. The aim of this study was to describe PP...
8.
Wesseloo R, Wierdsma A, van Kamp I, Munk-Olsen T, Hoogendijk W, Kushner S, et al.
Br J Psychiatry . 2017 Jul; 211(1):31-36. PMID: 28673946
Lithium is challenging to dose during pregnancy.To provide guidance for dosing lithium during pregnancy.Retrospective observational cohort study. Data on lithium blood level measurements ( = 1101), the daily lithium dose,...
9.
Wesseloo R, Liu X, Clark C, Kushner S, Munk-Olsen T, Bergink V
J Affect Disord . 2017 May; 218:394-397. PMID: 28501739
Background: Women with bipolar disorder are at high risk for relapse/recurrence postpartum. Among all mood stabilizers, lithium has the largest evidence base for efficacy in the peripartum period, but lamotrigine...
10.
Wesseloo R, Kamperman A, Munk-Olsen T, Pop V, Kushner S, Bergink V
Am J Psychiatry . 2015 Oct; 173(2):117-27. PMID: 26514657
Objective: Women with a history of bipolar disorder, postpartum psychosis, or both are at high risk for postpartum relapse. The aim of this meta-analysis was to estimate the risk of...